Your browser doesn't support javascript.
Multi-site proficiency testing for validation and standardization of assays to detect specific pathogen-free viruses, coronaviruses, and other agents in nonhuman primates.
Yee, JoAnn L; Grant, Richard; Haertel, Andrew J; Allers, Carolina; Carpenter, Amanda B; Van Rompay, Koen K A; Roberts, Jeffrey A.
  • Yee JL; Primate Assay Laboratory, California National Primate Research Center, University of California, Davis, California, USA.
  • Grant R; Primate Pathogen Detection Services Laboratory, Washington National Primate Research Center, University of Washington, Seattle, Washington, USA.
  • Haertel AJ; Oregon National Primate Research Center, Oregon Health Science University, Beaverton, Oregon, USA.
  • Allers C; Pathogen Detection and Quantification Core, Tulane National Primate Research Center, Tulane University, Covington, Louisiana, USA.
  • Carpenter AB; Primate Assay Laboratory, California National Primate Research Center, University of California, Davis, California, USA.
  • Van Rompay KKA; Primate Assay Laboratory, California National Primate Research Center, University of California, Davis, California, USA.
  • Roberts JA; Department of Pathology, Microbiology & Immunology, School of Veterinary Medicine, University of California, Davis, California, USA.
J Med Primatol ; 51(4): 234-245, 2022 08.
Article in English | MEDLINE | ID: covidwho-1794630
ABSTRACT
In efforts to increase rigor and reproducibility, the USA National Primate Research Centers (NPRCs) have focused on qualification of reagents, cross-laboratory validations, and proficiency testing for methods to detect infectious agents and accompanying immune responses in nonhuman primates. The pathogen detection working group, comprised of laboratory scientists, colony managers, and leaders from the NPRCs, has championed the effort to produce testing that is reliable and consistent across laboratories. Through multi-year efforts with shared proficiency samples, testing percent agreement has increased from as low as 67.1% for SRV testing in 2010 to 92.1% in 2019. The 2019 average agreement for the four basic SPF agents improved to >96% (86.5% BV, 98.9 SIV, 92.1 SRV, and 97.0 STLV). As new pathogens such as SARS coronavirus type 2 emerge, these steps can now be quickly replicated to develop and implement new assays that ensure rigor, reproducibly, and quality for NHP pathogen detection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Simian T-lymphotropic virus 1 Type of study: Prognostic study / Randomized controlled trials Limits: Animals Language: English Journal: J Med Primatol Year: 2022 Document Type: Article Affiliation country: Jmp.12586

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Simian T-lymphotropic virus 1 Type of study: Prognostic study / Randomized controlled trials Limits: Animals Language: English Journal: J Med Primatol Year: 2022 Document Type: Article Affiliation country: Jmp.12586